Similar articles

• Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities.

  Hemminki E. Hemminki E. Eur J Clin Pharmacol. 1981 Feb;19(3):157-65. doi: 10.1007/BF00561942. Eur J Clin Pharmacol. 1981. PMID: 7215412
• Number and type of psychotropic drugs on the Scandinavian market in 1950-1977.

  Hemminki E, Pesonen T, Hansen EH. Hemminki E, et al. Drug Intell Clin Pharm. 1981 Jan;15(1):27-37. doi: 10.1177/106002808101500105. Drug Intell Clin Pharm. 1981. PMID: 7274011
• [Use and control of psychotropic drugs is given priorty in Scandinavian drug research].

  Karlsson Y. Karlsson Y. Nord Med. 1977 Mar;92(3):90-2. Nord Med. 1977. PMID: 557789 Swedish. No abstract available.
• Regulatory concerns at various phases of drug development.

  Aurecchia S, Orloff D, Sobel S. Aurecchia S, et al. Am J Cardiol. 1998 Apr 23;81(8A):2F-4F. doi: 10.1016/s0002-9149(98)00250-1. Am J Cardiol. 1998. PMID: 9604895 Review. No abstract available.
• [Consumption of psychotropic drugs in Finland, Iceland, Norway and Sweden].

  Grímsson A, Idänpään-Heikkilä J, Lunde M, Olafsson O, Westerholm B. Grímsson A, et al. Nord Med. 1977 Feb;92(2):49-54. Nord Med. 1977. PMID: 320554 Review. Swedish. No abstract available.